<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1025-0255</journal-id>
<journal-title><![CDATA[Revista Archivo Médico de Camagüey]]></journal-title>
<abbrev-journal-title><![CDATA[Arch méd Camagüey]]></abbrev-journal-title>
<issn>1025-0255</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Camagüey]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1025-02552022000100073</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Enfoque terapéutico de la diabetes mellitus tipo 2 en la Atención Primaria ante situaciones especiales]]></article-title>
<article-title xml:lang="en"><![CDATA[Therapeutic approach of diabetes mellitus type 2 in Primary Care in special situations]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Magdariaga]]></surname>
<given-names><![CDATA[Alfredo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hierrezuelo-Rojas]]></surname>
<given-names><![CDATA[Naifi]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Johnson-Valenciano]]></surname>
<given-names><![CDATA[Suniel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferrera-Velázquez]]></surname>
<given-names><![CDATA[Lourdes Marbelys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Avila-Vazquez]]></surname>
<given-names><![CDATA[Marileidys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas Policlínico Camilo Torres Restrepo Servicio de Asistencia Médica]]></institution>
<addr-line><![CDATA[ Santiago de Cuba]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Ciencias Médicas Policlínico Ramón López Peña Servicio de Asistencia Médica]]></institution>
<addr-line><![CDATA[ Santiago de Cuba]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Ciencias Médicas Policlínico Carlos J. Finlay Servicio de Asistencia Médica]]></institution>
<addr-line><![CDATA[ Santiago de Cuba]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<volume>26</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1025-02552022000100073&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1025-02552022000100073&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1025-02552022000100073&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: Existe la necesidad imperiosa de individualizar cada tratamiento de diabetes mellitus tipo 2 según situaciones especiales de cada paciente diagnosticado con la enfermedad.  Objetivo: Describir el enfoque terapéutico de los pacientes con diabetes tipo 2.  Métodos:  Se realizó un estudio descriptivo y trasversal en 96 pacientes diagnosticados con diabetes mellitus tipo 2, pertenecientes al policlínico Camilo Torres Restrepo, en el periodo de enero- diciembre 2021. Se estudiaron variables como la edad, sexo, tipo de tratamiento, tratamiento individualizado, control metabólico y adherencia al tratamiento. Se utilizaron técnicas de estadística descriptiva como frecuencia absoluta y porcentaje para variables cualitativas así como medidas de tendencia central para variables cuantitativas. Resultados: Hubo un predominio de las edades más avanzadas (por encima de 60 años) con el 72,9 % de la casuística y del sexo femenino (58,3 %). El 97,0 % de los participantes recibieron tratamiento farmacológico y no farmacológico, el 21,8 % necesitó más de un fármaco. La metformina fue el fármaco más utilizado (37,5 %). El tratamiento de los pacientes diabéticos en situaciones especiales fue inadecuado, excepto en pacientes con sobrepeso y obesidad, los pacientes que tuvieron adherencia al tratamiento, lograron un mejor control metabólico de la enfermedad (48 %).  Conclusiones: El enfoque terapéutico en los pacientes estudiados fue inadecuado. El tratamiento de diabetes mellitus tipo 2 debe ser individualizado, desde un fundamento integral de la condición basal de cada paciente, al tener en cuenta sus comorbilidades para lograr una integralidad en las acciones en el nivel primario de prevención.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  There is an urgent need to individualize each diabetes mellitus type 2 treatment according to the special situations of each patient diagnosed with the disease.  Objective:  To describe the therapeutic approach of patients with diabetes type 2.  Methods : A descriptive and cross-sectional study was carried out in 96 patients diagnosed with diabetes mellitus type 2, belonging to the Camilo Torres Restrepo polyclinic, in the period from January to December 2021. Variables such as age, sex, type of treatment, individualized treatment, metabolic control and adherence to treatment were studied. Descriptive statistical techniques were used, such as absolute frequency and percentage for qualitative variables, as well as measures of central tendency for quantitative variables.  Results : There was a predominance of older ages (over 60 years) with 72.9 % of the casuistry and females (58.3 %). 97.0 % of the participants received pharmacological and non-pharmacological treatment, and 21.8% required more than one drug. Metformin was the most used drug (37.5 %). Treatment of diabetic patients in special situations was inadequate, except in overweight and obese patients, and patients who adhered to treatment achieved better metabolic control of the disease (48%).  Conclusions : The therapeutic approach in the studied patients was inadequate. The treatment of diabetes mellitus type 2 must be individualized, from a comprehensive basis of the baseline condition of each patient, taking into account their comorbidities to achieve comprehensive actions at the primary level of prevention.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[DIABETES MELLITUS TIPO 2/tratamiento farmacológico]]></kwd>
<kwd lng="es"><![CDATA[CUMPLIMIENTO Y ADHERENCIA AL TRATAMIENTO]]></kwd>
<kwd lng="es"><![CDATA[METFORMINA/uso terapéutico]]></kwd>
<kwd lng="es"><![CDATA[ANCIANO]]></kwd>
<kwd lng="es"><![CDATA[ATENCIÓN PRIMARIA DE SALUD]]></kwd>
<kwd lng="en"><![CDATA[DIABETES MELLITUS, TYPE 2/drug therapy]]></kwd>
<kwd lng="en"><![CDATA[TREATMENT ADHERENCE AND COMPLIANCE]]></kwd>
<kwd lng="en"><![CDATA[METFORMIN/therapeutic use]]></kwd>
<kwd lng="en"><![CDATA[AGED]]></kwd>
<kwd lng="en"><![CDATA[PRIMARY HEALTH CARE]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>International Diabetes Federation</collab>
<source><![CDATA[Atlas de la Diabetes de la FID]]></source>
<year>2019</year>
<edition>9na</edition>
<page-range>169</page-range><publisher-loc><![CDATA[Bruselas ]]></publisher-loc>
<publisher-name><![CDATA[FID]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arnold]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Licea]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contribución de la Epidemiología al estudio de la diabetes mellitus]]></article-title>
<source><![CDATA[Rev Cubana Hig Epidemiol]]></source>
<year>2017</year>
<volume>55</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Standards of medical care in diabetes -2018]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2017</year>
<volume>41</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[World health statistics 2017: monitoring health for the SDGs, Sustainable Development Goals]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Anuario Estadístico 2020]]></source>
<year>2021</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Dirección Nacional de Registros Médicos y Estadísticas de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Informe Mundial sobre la Diabetes]]></source>
<year>2016</year>
<page-range>86</page-range><publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saldarriaga Betancur]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfoque terapéutico de la Diabetes Mellitus tipo 2 en adultos. Más allá de una meta glucémica.]]></article-title>
<source><![CDATA[Med UPB]]></source>
<year>2018</year>
<volume>37</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>36-46</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tschöpe]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hanefeld]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Meier]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gitt]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Halle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bramlage]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes]]></article-title>
<source><![CDATA[Cardiovasc Diabetol]]></source>
<year>2013</year>
<volume>12</volume>
<numero>62</numero>
<issue>62</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Figueroa Villa]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gafas González]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Rodríguez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Brossard Peña]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[García Rios]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Valdiviezo Maygua]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dimensiones de calidad de vida afectadas en pacientes diabéticos]]></article-title>
<source><![CDATA[Rev cuba enferm]]></source>
<year>2020</year>
<volume>36</volume>
<numero>Internet</numero>
<issue>Internet</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Standards of Medical Care in Diabetes-2009]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2009</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pomares]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Jorge]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Alfonso]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia terapéutica y bienestar subjetivo en pacientes con diabetes mellitus tipo II]]></article-title>
<source><![CDATA[Rev Finlay]]></source>
<year>2019</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yanes Quesada]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Perich Amador]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzales Suárez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Yánez Quesada]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz Hernández]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez Díaz]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores clínicos relacionados con la hipertensión arterial en pacientes con trastornos de tolerancia a los carbohidratos]]></article-title>
<source><![CDATA[Rev cuban med gen integ]]></source>
<year>2017</year>
<volume>23</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arencibia-Alvarez]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Bell-Castillo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[George-Carrión]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Gallego-Galano]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[George-Bell]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de los pacientes con diabetes mellitus tipo 2 atendidos en el Hospital General Docente Dr. Juan Bruno Zayas Alfonso]]></article-title>
<source><![CDATA[Univ Méd Pinareña]]></source>
<year>2020</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Estrada Vaillant]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Hernández]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Izada Carnesoltas]]></surname>
<given-names><![CDATA[LT]]></given-names>
</name>
<name>
<surname><![CDATA[González Gil]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Quiñones Cabrera]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera Dorta]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínico-epidemiológicas de la Diabetes Mellitus tipo 2 en el Policlínico Milanés. Municipio Matanzas]]></article-title>
<source><![CDATA[Rev méd electrón]]></source>
<year>2017</year>
<volume>39</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1084-93</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Salvá]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Céspedes Hernández]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Piñera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[García Roche]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Balcindes Acosta]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Brechas en el manejo del paciente diabético tipo 2 en un área metropolitana de La Habana]]></article-title>
<source><![CDATA[Rev Finlay]]></source>
<year>2019</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arteaga Noriega]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cogollo Jiménez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz Monterroza]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Apoyo social y control metabólico en la diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Rev Cuid]]></source>
<year>2017</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1668-76</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bello Escamilla]]></surname>
<given-names><![CDATA[NV]]></given-names>
</name>
<name>
<surname><![CDATA[Montoya Cáceres]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia al tratamiento farmacológico en adultos mayores diabéticos tipo 2 y sus factores asociados]]></article-title>
<source><![CDATA[Gerokomos]]></source>
<year>2017</year>
<volume>28</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>73-7</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rincón]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Corredor]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia terapéutica en personas con diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Rev ciencia y cuidado]]></source>
<year>2017</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>40-59</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<collab>UK Prospective Diabetes Study (UKPDS) Group</collab>
<article-title xml:lang=""><![CDATA[Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1998</year>
<volume>352</volume>
<page-range>854-65</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boussageon]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Supper]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Bejan-Angoulvant]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kellou]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cucherat]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Boissel]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reappraisal of metformin efficacy in the treatment of type 2 diabetes: A meta-analysis of randomised controlled trials]]></article-title>
<source><![CDATA[PLoSMed]]></source>
<year>2012</year>
<volume>9</volume>
<numero>Internet</numero>
<issue>Internet</issue>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trujillo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Vicente]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Rivas]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de los pacientes diabéticos tipo 2 ingresados en el Centro de Atención al Diabético de Cienfuegos]]></article-title>
<source><![CDATA[Rev Finlay]]></source>
<year>2016</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>281-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leyva]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Masmout]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Carbonel]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
<name>
<surname><![CDATA[Gámez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Dueñas]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización clínico epidemiológica de pacientes con diabetes mellitus de tipo 2]]></article-title>
<source><![CDATA[MEDISAN]]></source>
<year>2017</year>
<volume>17</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>5032</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arnold]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Castelo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Licea]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comportamiento de indicadores epidemiológicos de morbilidad por diabetes mellitus en Cuba, 1998-2009]]></article-title>
<source><![CDATA[Rev Perú epidemiol]]></source>
<year>2017</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Asenjo]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relación entre estilo de vida y control metabólico en pacientes con Diabetes Mellitus Tipo 2 de Chota, Perú]]></article-title>
<source><![CDATA[Rev Med Hered]]></source>
<year>2019</year>
<volume>31</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>101-7</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aloudah]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[NW]]></given-names>
</name>
<name>
<surname><![CDATA[Aljadhey]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Araujo-Soares]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Alrubeaan]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Watson]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication adherence among patients with Type 2 diabetes: A mixed methods study]]></article-title>
<source><![CDATA[PloS one]]></source>
<year>2018</year>
<volume>13</volume>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Carbajales]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
<name>
<surname><![CDATA[Carbajales]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínicas epidemiológicas de la diabetes mellitus en pacientes de un consultorio médico]]></article-title>
<source><![CDATA[RMIJ]]></source>
<year>2020</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1-13</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramos-Rangel]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Morejón-Suárez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Valdivia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Reina-Suárez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rangel-Díaz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera-Macías]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia terapéutica en pacientes con diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Revista Finlay]]></source>
<year>2017</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mora]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia al tratamiento en personas con diabetes mellitus tipo 2 en México: Estudio de meta-análisis]]></article-title>
<source><![CDATA[Psicumex]]></source>
<year>2022</year>
<volume>12</volume>
<page-range>493</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cordero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Alba]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características sociodemográficas asociadas a la adherencia del tratamiento en adultos con Diabetes Tipo 2]]></article-title>
<source><![CDATA[Rev Horizonte sanitario]]></source>
<year>2022</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>276-81</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alfaro Mauricio]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<source><![CDATA[Calidad de la Atención Farmacéutica y adherencia al tratamiento en pacientes diabéticos. Hospital I La Esperanza EsSalud. Trujillo, 2021]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Trujillo ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Cesar Vallejo]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
